expert roundtables

Myeloproliferative Neoplasms: Risk Stratification and Response Evaluation
Oncology

Myeloproliferative Neoplasms: Risk Stratification and Response Evaluation

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Polycythemia Vera: Factors That May Warrant a Change in Cytoreductive Therapy
Oncology

Polycythemia Vera: Factors That May Warrant a Change in Cytoreductive Therapy

expert roundtables
By Katherine Walsh, MD, FACP; Rami S. Komrokji, MD; Ruben A. Mesa, MD, FACP
Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia
Oncology

Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Recommendations for the Use of Maintenance and Consolidation Therapy in Chronic Lymphocytic Leukemia
Oncology

Recommendations for the Use of Maintenance and Consolidation Therapy in Chronic Lymphocytic Leukemia

expert roundtables
By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD
Pathobiology-Guided Therapy in Rheumatoid Arthritis
Rheumatology

Pathobiology-Guided Therapy in Rheumatoid Arthritis

expert roundtables
By Eric M. Ruderman, MD; Jeffrey R. Curtis, MD, MS, MPH; Leonard H. Calabrese, DO
Load More